Menü
01.03.2024:
We are happy to welcome our new colleague Dr. Pabitra Nandy as Head of Microbiome Solutions and Bioinformatics.
01.01.2024:
ACARYON gained a grant from the BMBF to develop a new non-antibiotic application against clostridium difficile-infections.
01.04.2023:
We are happy to welcome our new colleague M.Sc. U. Valérie. as manager scientific database.
01.02.2023:
We are happy to welcome our new colleague M.Sc. Iryna Hrushetska.
30.11.2022:
ACARYON gained a grant from the state of Berlin to develop its microbiome cultivation platform.
07.02.2022:
We are happy to announce the launch of our All in One Human Microbiome Analysis Platform.
14.01.2022:
We are happy to welcome our new colleague M.Sc. Katharina Werner.
15.11.2021:
We are happy to welcome our new colleague: M.Sc. Raoul Goterris Aldea.
15.09.2021:
ACARYON gained a grant from the Region Berlin to develop a new technology platform for the development of non antibiotic anti-infection agents.
01.09.2021:
ACARYON moves into its new laboratory on the Berlin-Buch Biotechnology campus.
ACARYON GmbH • Biotech Campus Berlin-Buch
Robert-Rössle-Str. 10 • Building D79 • 13125 Berlin (Germany)
One of the most important and recent paradigm shifts in medicine is the recognition of the central role that the gut microbiome plays in human health. However, the implementation of research findings in concrete applications is limited by the lack of specific analysis systems. Mainly, there is a lack of reliable and standardized in vitro platforms allowing to run high throughput analysis on the human microbiome. With the financial support of the EU and the state of Berlin, ACARYON develops a new in vitro human microbiome model that aims mimicking the natural gut conditions, thereby allowing to ensure a stable composition of the human microbiome in the system for more than 48 hours.